Antihypertensive pharmacogenetics: missed opportunity.
作者信息
Padmanabhan Sandosh
出版信息
J Hypertens. 2010 Oct;28(10):2007-9. doi: 10.1097/HJH.0b013e32833f2f56.
PMID:20844368
Abstract
摘要
相似文献
1
Antihypertensive pharmacogenetics: missed opportunity.
J Hypertens. 2010 Oct;28(10):2007-9. doi: 10.1097/HJH.0b013e32833f2f56.
2
Pharmacogenetics of antihypertensive treatment.
Vascul Pharmacol. 2006 Feb;44(2):107-18. doi: 10.1016/j.vph.2005.09.010. Epub 2005 Dec 13.
3
[Which antihypertensive therapy is indicated in type 2 diabetic patients?].
Dtsch Med Wochenschr. 2002 Jul 12;127(28-29):1543-4. doi: 10.1055/s-2002-32753.
4
[Treatment of hypertension in patients with adult-onset diabetes].
Duodecim. 1999;115(10):1147-53.
5
Long-term safety of antihypertensive therapy.
Prog Cardiovasc Dis. 2006 Jul-Aug;49(1):16-25. doi: 10.1016/j.pcad.2006.06.002.
6
Back to basics: diuretics as first-line agents in the treatment of hypertension.
J Am Geriatr Soc. 2004 Jul;52(7):1210-1. doi: 10.1111/j.1532-5415.2004.52324.x.
7
[Management of hypertension in upheaval?].
Dtsch Med Wochenschr. 2005 Nov 18;130(46):2627. doi: 10.1055/s-2005-922044.
8
[Antihypertensive treatment in the type 2 diabetic].
Nephrologie. 2000;21(4):203-4.
9
The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
Nephrol Dial Transplant. 2008 Nov;23(11):3389-91. doi: 10.1093/ndt/gfn455. Epub 2008 Aug 7.
10
[Development of various forms of hypertension and a new assessment of antihypertensive medication].
Dtsch Med Wochenschr. 2006 Jun 23;131(25-26):1449-51. doi: 10.1055/s-2006-946598.
Zotero 插件